MB

MPM BioImpact Portfolio holdings

AUM $577M
1-Year Est. Return 8.33%
This Quarter Est. Return
1 Year Est. Return
+8.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$427M
AUM Growth
+$52.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Sells

1 +$5.73M
2 +$5.57M
3 +$4.94M
4
NTLA icon
Intellia Therapeutics
NTLA
+$4.94M
5
VRDN icon
Viridian Therapeutics
VRDN
+$3.38M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$77.9M 18.23%
7,648,268
2
$26.7M 6.26%
3,289,470
+2,073
3
$26.1M 6.1%
1,857,136
-545
4
$22.6M 5.29%
10,715,620
+3,139
5
$19.1M 4.47%
1,745,943
6
$18.8M 4.41%
+1,264,759
7
$17.8M 4.16%
294,576
+386
8
$17M 3.98%
478,234
-819
9
$16.9M 3.95%
53,279
+69
10
$16.4M 3.83%
528,150
+692
11
$14.4M 3.38%
611,181
+411
12
$12M 2.8%
1,639,849
13
$11.7M 2.73%
382,598
-162,041
14
$10.2M 2.38%
715,883
-256
15
$9.86M 2.31%
549,078
-107,640
16
$9.47M 2.21%
40,910
+51
17
$9.4M 2.2%
230,696
-65
18
$9.39M 2.2%
664,986
+762
19
$9.35M 2.19%
323,742
+123,742
20
$9.22M 2.16%
2,388,011
21
$9.16M 2.14%
832,017
-520,116
22
$9.04M 2.12%
3,847,232
-140,735
23
$8.9M 2.08%
638,163
-219,777
24
$7.84M 1.83%
273,408
25
$7.43M 1.74%
93,387
-199